Dwayne Soisson
Chief Operating Officer presso VAXXINITY, INC.
Profilo
Dwayne Soisson is currently working as Vice President-Operations at Vaxxinity, Inc. He previously worked as Vice President-Operations at Dendreon Pharmaceuticals LLC.
He holds an MBA degree from James Madison University and an undergraduate degree from the University of Delaware.
Posizioni attive di Dwayne Soisson
| Società | Posizione | Inizio |
|---|---|---|
| VAXXINITY, INC. | Chief Operating Officer | - |
Precedenti posizioni note di Dwayne Soisson
| Società | Posizione | Fine |
|---|---|---|
Dendreon Pharmaceuticals LLC
 Dendreon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Dendreon Pharmaceuticals LLC is a commercial-stage biopharmaceutical company that specializes in developing, manufacturing, and commercializing cell therapies. Dendreon Pharmaceuticals is based in Seal Beach, CA. The private company is a pioneer in cellular therapy, targeting cancer and transforming lives. Dendreon has proven expertise in cellular therapy and ensures product quality through its experience in the field. The company was founded in 1992 by Edgar G. Engleman and Samuel Strober, and the CEO is John C O'Neill. | Chief Operating Officer | - |
Formazione di Dwayne Soisson
| James Madison University | Masters Business Admin |
| University of Delaware | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| VAXXINITY, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Dendreon Pharmaceuticals LLC
Dendreon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Dendreon Pharmaceuticals LLC is a commercial-stage biopharmaceutical company that specializes in developing, manufacturing, and commercializing cell therapies. Dendreon Pharmaceuticals is based in Seal Beach, CA. The private company is a pioneer in cellular therapy, targeting cancer and transforming lives. Dendreon has proven expertise in cellular therapy and ensures product quality through its experience in the field. The company was founded in 1992 by Edgar G. Engleman and Samuel Strober, and the CEO is John C O'Neill. | Health Technology |
- Borsa valori
- Insiders
- Dwayne Soisson
